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Phosphorylation of the insulin receptor substrates (Irs)
on serine residues—typified by Ser307 of rodent
Irs1—is thought to mediate insulin resistance. To
determine whether Ser307 negatively regulates Irs1
in vivo, we generated knockin mice in which Ser307
(human Ser312) was replaced with alanine (A/A).
Unexpectedly, A/A mice that were fed a high-fat diet
developed more severe insulin resistance than control
mice, accompanied by enhanced pancreatic compen-
sation and impaired muscle insulin signaling. Chow-
fed mice whose livers lacked Irs2 but retained a single
knockin allele (A/lox::LKO2) were profoundly insulin
resistant (versus +/lox::LKO2 mice), and their hepato-
cytes showed impaired insulin signaling ex vivo. Simi-
larly, mutant A307 Irs1 adenovirus only partially
restored the response to injected insulin in mice lack-
ing hepatic Irs1 and Irs2. Thus, contrary to the results
of cell-based experiments, Ser307 in mice is a positive
regulatory site that moderates the severity of insulin
resistance by maintaining proximal insulin signaling.
INTRODUCTION
Insulin resistance, particularly in skeletal muscle, may underlie
progression of type 2 diabetes in otherwise healthy persons (Pe-
tersen et al., 2007). Tissue responsiveness to insulin requires the
Irs1 and Irs2 proteins (Dong et al., 2008), which are phosphory-
lated by the insulin receptor (IR) on tyrosines to recruit the
phosphatidylinositol 30 kinase (PI3K). Production of phosphatidy-
linositol 3,4,5-trisphosphate (PIP3) by PI3K in turn stimulates the
activation of Akt by Pdk1, initiating diverse signaling pathways
(White, 2006). By contrast, serine and threonine (Ser/Thr) phos-
phorylation of Irs1 by multiple kinases in response to inflamma-
tory cytokines, fatty acids, and insulin itself can impair insulin
signaling in cultured cells (Zick, 2005). Of more than 200 Ser/Thr
residues in Irs1, around 30 are known to be phosphorylated in
insulin-treated cells or human muscle (Giraud et al., 2007; Yi
et al., 2007). Hyperactivation of the nutrient- and insulin-
stimulated mTORC1/S6k1 pathway causes extensive Ser/Thr
phosphorylation and degradation of Irs1 and diminished Akt
activation (Harrington et al., 2004; Shah et al., 2004). However,
reduced Irs1 protein expression is typically not seen in human84 Cell Metabolism 11, 84–92, January 6, 2010 ª2010 Elsevier Inc.diabetic muscles (reviewed in Leng et al., 2004). Consistent with
the hypothesis that insulin resistance instead emerges from
particular patterns of Irs protein modification, phosphorylation
of Ser312 and Ser636/639 of Irs1 is elevated in skeletal muscle
of prediabetic humans (Morino et al., 2005), whereas the cognate
sites (Ser307, Ser632/635) are hypophosphorylated in tissue from
highly insulin-sensitive S6k1/ mice (Um et al., 2004).
In cultured cells, mutation of Ser307 was shown to protect
against tumor necrosis factor alpha (TNFa)-induced inhibition
of Irs1 tyrosine (Tyr) phosphorylation via the Jnk kinase pathway
(Aguirre et al., 2000); thus, Ser307 phosphorylation is frequently
cited as a cause of stress-induced insulin resistance. Increased
Ser307 phosphorylation is seen in ob/ob and high-fat-fed mice,
which integrate the inflammatory, hyperinsulinemic, and dyslipi-
demic features of type 2 diabetes (Hirosumi et al., 2002; Um
et al., 2004). Further, ob/ob mice lacking Jnk1 exhibit reduced
Ser307 phosphorylation and improved insulin sensitivity, with
decreased circulating insulin concentration (Hirosumi et al.,
2002). In skeletal muscle of humans and rodents, infusion of
triglyceride impairs insulin-stimulated glucose disposal through
a mechanism involving decreased Irs1-associated PI3K activity
(Kruszynska et al., 2002; Yu et al., 2002). In mice, this is accom-
panied by increased phosphorylation of Ser307 (Yu et al., 2002),
potentially by the PKCq kinase (Kim et al., 2004). Hyperinsuline-
mic-euglycemic clamp—which may mimic the hyperinsulinemia
of diabetes—is also sufficient to stimulate phosphorylation of
Ser307 and many other sites on Irs1 in human muscle (Yi et al.,
2007). To experimentally address the function of Ser307 in whole
animals, we prepared knockin mice in which this residue could
not be phosphorylated. Analysis of these mice indicates, surpris-
ingly, that Irs1 Ser307 is required to maintain normal insulin
signaling, particularly during nutrient and genetic stress.
RESULTS
Generation of Mutant and Control Knockin Mice
Mice lacking Ser307 in Irs1 (A/A mice) were generated by replac-
ing the endogenous Irs1 gene with a point-mutated copy
(Ser307Ala, or A allele) (see Figure S1A available online). Knockin
mice (S/S) bearing a nonmutated allele (S) were generated by
the same method to control for the effect of a residual 66 bp
fragment in the 30 noncoding region of the knockin alleles
(Figure S1B). Normal splicing of Irs1 mRNA in knockin mice
was confirmed by RT-PCR, and genomic sequencing revealed
no unexpected differences in Irs1 noncoding or protein-coding
sequences (Figures S1C and S1A). Mouse embryo fibroblasts
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Figure 1. Irs1 Ser307Ala Knockin Mice Are Insulin Resistant versus Control Knockin and WT Mice
(A and B) Immunoblot analysis of insulin signaling in control (S/S) and mutant (A/A) knockin MEFs; cells were maintained in 10% serum (FBS), or fasted () 16 hr
before treatment with 100 nM insulin; IP, immunoprecipitation; IB, immunoblot; s/r, stripped/reprobed membrane.
(C) DEXA analysis of 16-week-old WT (+/+), control knockin (S/S), and mutant knockin mice (A/A). Bars show mean ± SEM; BMD, bone mineral density.
(D and E) Glucose tolerance test and (E) insulin tolerance test in 5-month-old chow-fed mice; AUC, area under curve (mean ± SEM, arbitrary units).
(F) Fasted plasma insulin at time = 0 of GTT; box, interquartile range (IQR); horizontal bar, median; vertical bar, 95% of distribution. The exclusion of tailing outliers
(>1.5 3 IQR, d and >3 3 IQR,5) gave trimmed medians of 159 (+/+), 175 (S/S) and 404 pg/ml (A/A), yielding significance (p < 0.05) for the comparison of A/A
versus S/S insulin distributions. *p < 0.05.
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Irs1 Ser307 Promotes Insulin Sensitivity in Mice(MEFs) derived from E13.5 littermate A/A and S/S embryos were
used to confirm mutation of Ser307 by immunoblot. Basal Tyr
phosphorylation of Irs1 was high in both cell types, obscuring
insulin-stimulated Tyr phosphorylation of Irs1; however, phos-
phorylation of Ser307 was evident at all times in S/S, but not
A/A, MEFs (Figure 1A). Despite this difference, insulin-stimulated
phosphorylation of Akt and its targets Foxo1 and Tsc2—as well
as indirect target S6k—was indistinguishable between S/S and
A/A MEFs (Figure 1B). Irs2 concentrations were also unaffected.
Thus, the mutation of Ser307 did not markedly alter insulin
signaling in these primary cells.
Analysis of Glucose Homeostasis in A/A Mice
To evaluate the function of Ser307 in whole-body glucose
homeostasis, A/+ and S/+ mice were backcrossed to C57BL/6Cmice, which are predisposed to diet-induced obesity and insulin
resistance (Surwit et al., 1988). Male A/A, S/S, and wild-type
(WT, +/+) mice (n = 11–17 per group) were fed a regular chow
diet. The cumulative function of Irs1 in growth and development
was examined at 4 months using dual X-ray absorptiometry
(DEXA) (Figure 1C). Compared to +/+ mice, both S/S and A/A
mice had slightly decreased (5%–10%) body mass, length,
and bone mineral density (BMD) but unchanged adiposity,
revealing a small effect of knockin at the Irs1 locus independent
of Ser307 status. Glucose and insulin tolerance tests (GTT, ITT),
summarized as areas under curves (AUC), were performed at
5 months of age. In GTTs, glucose excursion was slightly greater
in A/A than in S/S or +/+ mice, reaching significance versus S/S
mice (A/A, 2.47 ± 0.08 versus S/S, 2.00 ± 0.12; p < 0.05)
(Figure 1D). In ITTs—which measure the response to injectedell Metabolism 11, 84–92, January 6, 2010 ª2010 Elsevier Inc. 85
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Irs1 Ser307 Promotes Insulin Sensitivity in Miceinsulin—the AUC for A/A mice was insignificantly elevated, but
the maximum drop in blood glucose in A/A mice (at 60 min)
tended to be less than in S/S mice (p = 0.10) and was significantly
less than in +/+ mice (p < 0.05). By contrast, S/S and +/+ mice
were indistinguishable by GTT or ITT.
Insulin resistance is compensated by increased insulin secre-
tion and pancreatic b cell hyperplasia to maintain normoglyce-
mia. Although fasting blood glucose was equivalent in A/A, S/S,
and +/+ mice (time = 0 min, Figure 1D), the median fasting
plasma insulin in A/A mice (465 pg/ml) was >2.5-fold higher
than that in S/S mice (177 pg/ml, p = 0.07, r = 0.44) or +/+
mice (163 pg/ml, p < 0.05, r = 0.48) (Figure 1F). Despite
marginal significance in the comparison of A/A and S/S insulin
concentrations, the effect size (r) was consistent with a substan-
tial effect of Ser307 status on their distributions. To limit the influ-
ence of extreme values, insulin concentrations were reanalyzed
excluding tailing outliers (>1.5 times group interquartile ranges,
Figure 1F). After trimming, the median insulin in A/A mice (404
pg/ml) was still significantly higher than in either control group
(S/S mice: 175 pg/ml, p < 0.05, r = 0.51; +/+ mice 159 pg/ml,
p < 0.01, r = 0.53). As in the GTT and ITT assays, no difference
was seen between S/S and +/+ mice (NS, r = 0.16), demon-
strating that knockin per se had no effect on insulin sensitivity.
Compatible with these data, we previously observed normal
fasting insulinemia in mice homozygous for the similarly targeted
Irs1lox (lox) conditional allele (Dong et al., 2008).
Ser307 Protects Mice against High-Fat-Diet-Induced
Insulin Resistance
The strong positive skew of insulin concentrations in A/A mice
implied that mutation of Ser307 allowed a transition to insulin
resistance dependent upon other factors. To sensitively test for
such an effect—while minimizing the influence of genetic varia-
tion—two cohorts of male A/A, A/+, and +/+ mice were either
fed regular chow (chow, n = 7–10 per group) or switched to
a high-fat diet (HFD, n = 9–10 per group) beginning at 4 weeks
of age. Subsequent comparisons tested for effects of complete
or partial absence of Ser307 in A/A or A/+ mice.
Consumption of HFD was equivalent between A/A, A/+,
and +/+ mice (data not shown), causing significant weight gain
after 8 weeks (Figure 2A). DEXA analysis of HFD-fed mice
showed no effect of Ser307 mutation on body mass, length, or
adiposity (p < 0.05, Figure S2A). Fasting blood glucose was
increased on HFD for all groups, while fed glucose was nearly
unaffected (Figure 2B). GTT and ITT assays at 20 weeks of age
revealed no significant reduction in insulin sensitivity of chow-
fed A/A or A/+ mice (Figures 2C and 2E). By contrast, HFD-fed
A/A mice were significantly glucose intolerant (AUC, A/A mice,
4.79 ± 0.27; +/+ mice, 3.79 ± 0.20, p < 0.05, r = 0.61), whereas
glucose excursion of A/+ mice was between that of A/A and +/+
mice (Figure 2D). Responses of HFD-fed mice to insulin in the ITT
followed the same pattern (Figure 2F); however, high within-
group variance precluded a finding of significance (H[2] = 5.34,
p = 0.07; post hoc comparisons omitted).
Robust evidence of insulin resistance in A/A and A/+ mice
was seen in pancreatic adaptations to hyperglycemia (Figures
2G and 2H). In the small chow-fed cohort, both fasting insulin
and b cell area were absolutely, but insignificantly, higher in A/A
and A/+ mice than in +/+ mice. However, on HFD, the median86 Cell Metabolism 11, 84–92, January 6, 2010 ª2010 Elsevier Inc.fasting insulin concentrations of A/A and A/+ mice (1.28 and
1.67 ng/ml) were substantially elevated (1.9- to 2.5-fold) over
that of +/+ mice (0.68 ng/ml) (NS, r = .47; and p < 0.025,
r = 0.66, respectively). Moreover, HFD caused pancreatic
b cell areas of both A/A and A/+ mice to increase significantly
(2.5-fold) over that of +/+ controls (p < 0.01, r = 0.73; and
p < 0.05, r = 0.54, respectively). In limited testing, we also
found that homozygosity for the Irs1 A allele had no effect on
development of obesity and glucose intolerance in ob/ob mice
(Figures S2D and S2E), in whose tissues Ser307 phosphoryla-
tion is elevated (Hirosumi et al., 2002). Thus, substitution of
Ser307 with alanine failed to ameliorate—and even exacer-
bated—insulin resistance caused by diet- and genetic-induced
obesity.
Mutation of Ser307 Fails to Block HFD-Induced
Desensitization of Insulin Signaling
Consistent with published data (Um et al., 2004), HFD increased
both basal and insulin-stimulated Ser307 phosphorylation in
muscle of +/+ and A/+ mice (Figure 3A). Insulin-stimulated Akt
T308 phosphorylation—dependent on both Irs1 and Irs2—was
not significantly diminished in HFD-fed A/A muscles (Figure 3B).
To further gauge the effects of reduced Ser307 phosphorylation,
Irs1 Tyr phosphorylation (pTyr) and PI3 kinase (p85) binding were
compared in Irs1 immunoprecipitates (IPs). In chow-fed mouse
muscles, pTyr and p85 binding were roughly equivalent between
+/+, A/+, and A/A samples. By contrast, HFD-fed mouse
muscles of each genotype showed decreased insulin stimulation
(fold over basal) of Irs1 Tyr phosphorylation and p85 binding, and
this desensitization of insulin signaling was more pronounced in
muscle from A/+ and A/A mice than from +/+ mice (Figure 3C).
Anti-Irs2 IPs showed equivalent signaling via this pathway in
chow-fed mouse muscles, with similar degrees of desensitiza-
tion by HFD across all genotypes (Figure 3D). In the liver, the
effects of Ser307 mutation on signaling did not follow as clear
a pattern. Insulin-stimulated binding of p85 to Irs1 and Irs2 was
moderately reduced in chow-fed A/A liver (Figures S2B and
S2C), but this did not translate into decreased Akt (Thr308) phos-
phorylation. However, Akt phosphorylation was reduced signifi-
cantly in HFD-fed A/A liver (Figure S2B). Thus, although signaling
experiments revealed only modest differences between A/A and
control tissues, the overall pattern of proximal insulin signaling
was incompatible with an insulin-sensitizing effect of reduced
Ser307 phosphorylation.
The insulin- and nutrient-stimulated kinase S6k1 phosphory-
lates Irs1 at Ser302, as well as other putatively inhibitory sites
(Harrington et al., 2004). Thus, its activating phosphorylation
was assayed in liver of chow-fed mice that were fasted overnight
and refed for 1–2 hr. However, S6k Thr389 phosphorylation
did not differ between A/A and +/+ mice (Figure 3E), and
immunoblotting also failed to show elevated Irs1 Ser302 phos-
phorylation in A/A liver (data not shown). Further, no significant
difference was observed in the phosphorylation of nine Irs1
Ser/Thr sites (save Ser307) between Irs1-deficient primary
hepatocytes reconstituted with WT or mutant (A307) Irs1 adeno-
virus (Figure 3F). Thus, insulin resistance in A/A mice appeared
to owe specifically to mutation of Ser307, rather than to activa-
tion of feedback pathways that influence phosphorylation at
other tested sites.
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Figure 2. Ser307 Protects Mice against
High-Fat-Diet-Induced Insulin Resistance
(A) Body weight gain (mean ± SEM) in mice fed
regular chow (chow) or HFD.
(B) Effect of diet on fasting and fed blood glucose
(mean ± SEM) at 5 months of age.
(C–F) Glucose tolerance tests (C and D) and
insulin tolerance tests (E and F) on 5-month-old
mice maintained on chow or HFD. Graphs show
mean ± SEM at each point; *p < 0.05; NS, not
significant for area under curve.
(G) Fasting plasma insulin concentrations (mean ±
SEM) at time = 0 of GTT in chow- and HFD-fed
mice; horizontal bars, median values.
(H) b cell area (pixel percent, mean ± SEM) in
pancreatic sections from chow- and HFD-fed
mice. *p < 0.05; NS, not significant.
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by Deletion of Hepatic Irs2
We previously reported that mice with Alb-Cre-mediated dele-
tion of Irs2 in hepatocytes (LKO2 mice) are nearly normal,
whereas mice lacking hepatic Irs1 and Irs2 (LDKO) are profoundly
insulin resistant (Dong et al., 2008). Because insulin resistance in
chow-fed A/A mice could be obscured by normal Irs2 signaling,
we re-examined the insulin sensitivity of +/+ and A/A mice on theCell Metabolism 11, 84–9LKO2 mouse background. By crossing
A/+ mice to LDKO mice, we produced
(Cre+) male LKO2 mice whose livers
retained a WT or mutant Irs1 allele in
double or single copy. These mice were
compared at 24 weeks of age, with
LDKO littermates included for qualitative
comparison. In GTTs, glucose tolerance
was correlated with Irs1 allelic dose and
identity: +/+::LKO2 > +/lox::LKO2 > A/A::
LKO2 > A/lox::LKO2 > LDKO (Figures 4A
and 4C). Strikingly, A/lox::LKO2 mice—
but not +/lox::LKO2 mice—showed
severe glucose intolerance similar to
that of LDKO mice, suggesting that
A307Irs1 only weakly mediated the insulin
signal. Further, A/A::LKO2 mice were
significantly glucose intolerant versus
+/+::LKO2 and were indistinguishable
from +/lox::LKO2 mice. In ITTs (Figures
4B and 4C), A/lox::LKO2 mice—but not
+/lox::LKO2 mice—showed significant
insulin resistance that was only slightly
improved compared to DKO mice; as in
the GTT assay, A/A::LKO2 mice re-
sponded similarly to +/lox::LKO2 mice.
Fasting insulin concentrations—indica-
tive of compensation for insulin resis-
tance—were in the same order as
glucose excursion in the GTT (Figure 4D).
Fasting insulinemia was significantly
increased (p < 0.05) in both A/lox::LKO2
and A/A::LKO2 mice. As in the GTTand ITT assays, A/A::LKO2 mice did not differ significantly
from +/lox::LKO2 mice.
Defective Insulin Signaling by A307Irs1
in Hepatocytes Ex Vivo
The profound insulin resistance of A/lox::LKO2 mice was of
particular interest because, excluding their hepatocytes, these
mice were the practical equivalent of A/+ mice, in which we2, January 6, 2010 ª2010 Elsevier Inc. 87
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Figure 3. Mutation of Ser307 Fails to Protect against HFD-Induced Desensitization of Insulin Signaling
(A–D) (A) Immunoblot analysis of basal () and insulin-stimulated (+) Ser307 phosphorylation in hindlimb muscle of 5- to 6-month-old mice fed chow (Chow) or
HFD. Immunoprecipitated Irs1 (IP: Irs1) was detected using a phospho-specific antibody against 15 residues of mouse Irs1. (B) Corresponding Akt (Thr308) phos-
phorylation. (C and D) Immunoprecipitation (IP:) and immunoblot analysis of insulin signaling by Irs1 (C) or Irs2 (D) in muscle of chow- and HFD-fed mice; pTyr,
phosphotyrosine. In (A)–(D), the estimated means of phosphotyrosine, p85, or phospho-Thr308Akt signals (see Experimental Procedures) were normalized to the
average total Irs1, Irs2, or tubulin concentrations; *, significant difference (Bonferroni, p < 0.05) versus unstimulated; #, significant difference (Bonferroni, p < 0.05)
between indicated insulin-stimulated samples.
(E) Immunoblot analysis of p70 S6 kinase (Thr389) phosphorylation (mean ± SEM) in livers of overnight fasted mice refed for 1 or 2 hr. Mice were previously fed
chow diet.
(F) Immunoblot analysis of Irs1 Ser/Thr phosphorylation. Primary hepatocytes from mice lacking hepatic Irs1 and Irs2 (‘‘LDKO’’ Dong et al., 2008) were infected
with wild-type (Ad-WT) or mutant (Ad-A307) Irs1 adenovirus for 24 hr, then treated as shown after 16 hr of serum starvation. Relative Irs1 phosphorylation (mean ±
SEM) at each site is graphed as fold of Ad-WT-infected cells without insulin ().
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Figure 4. In Vivo and Ex Vivo Function of A307Irs1 in the Absence of Irs2-Mediated Signaling
(A and B) GTT and (B) ITT of 6-month-old mice lacking hepatic Irs2 (LKO2::) with varying Irs1 allelic composition. Owing to the action of Cre recombinase on the
Irs1lox allele (lox), A/lox::LKO2 and +/lox::LKO2 mice retained a single active Irs1 allele.
(C and D) Areas under GTT and ITT curves (AUC), with corresponding initial blood glucose and (D) insulin concentrations. LDKO mice are shown for qualitative
comparison. Labels show Irs1 genotype only. Data are mean ± SEM; *p < 0.05.
(E) Insulin signaling in hepatocytes of 10-week-old +/lox::LKO2 and A/lox::LKO2 mice. IP, immunoprecipitation; IB, immunoblot.
(F) Quantitation of blots in (E); d, +/lox::LKO2; B, +/lox::LKO2. Signals were normalized to the average value in 20 nM insulin-stimulated +/lox::LKO2 cells
measured in duplicate in two separate experiments. Data represent mean values ± standard deviation. *p < 0.05 by Student’s t test.
(G) Insulin tolerance (mean ± SEM at each point) in LDKO mice infected with wild-type (+Ad-WT) or mutant (+Ad-A307) Irs1 adenovirus. Insulin tolerance in nonin-
fected, Cre-negative double-floxed mice (FF) is shown for qualitative comparison.
(H) Maximum hypoglycemic response (time = 30 min) during the insulin tolerance test in (G); box, interquartile range; horizontal bar, median; vertical bar, 95% of
distribution. *p < 0.05.
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Irs1 Ser307 Promotes Insulin Sensitivity in Miceobserved glucose tolerance, insulin sensitivity, and fasting
insulin similar to those in WT mice (i.e., A/+ versus +/+, chow
diet, Figures 2C, 2E, and 2G). Thus, it appeared that the insulin
resistance of A/lox::LKO2 versus +/lox::LKO2 mice owed specif-
ically to reduced function of the A307Irs1 protein in liver hepato-
cytes. To test this hypothesis, primary hepatocytes were isolated
from 10-week-old A/lox::LKO2 and +/lox::LKO2 males, at which
time these mice did not yet differ by GTT (data not shown). These
cells expressed equivalent levels of Irs1, and stimulation with
insulin resulted in similar degrees of Tyr phosphorylation in Irs1
IPs (Figures 4E and 4F). In contrast, insulin-stimulated binding
of the p85 (regulatory) and p110a (catalytic) subunits of PI3K to
Irs1 was significantly reduced in A/lox::LKO2 hepatocytes (p <
0.05). As in muscles of HFD-fed A/A mice, however, downstream
activation of Akt (T308 phosphorylation) was not significantly
impaired.
A307Irs1 Adenovirus Incompletely Restores Insulin
Sensitivity in LDKO Mice
To control for peripheral or developmental influences on liver
A307Irs1 function, we reconstituted livers of LDKO mice using
WT or mutant Irs1 adenoviruses (Ad-WT and Ad-A307; n = 11,
12). Rescue of insulin sensitivity in the infected mice was gauged
by GTT and ITT; for qualitative comparison, we included non-
infected control mice (FF; identical to LDKO, but lacking Alb-
Cre). Perhaps owing to incomplete pancreatic compensation in
the young (6- to 8-week-old) LDKO recipients, neither virus
restored normal glucose tolerance in GTTs (data not shown).
By contrast, insulin sensitivity in ITTs was better restored in
mice that received WT Irs1 adenovirus (Figure 4G), and the
maximum hypoglycemic response was significantly greater in
Ad-WT- than in Ad-307-infected mice (30 min time point,
Figure 4H). These data are compatible with reduced function of
the A307Irs1 protein and further support that Ser307 or its phos-
phorylation contributes to normal signaling by Irs1.
DISCUSSION
The requirement of Ser307 for insulin sensitivity in knockin mice
runs counter to prevailing notions about the function of this phos-
phorylation site. To date, however, almost all of the evidence
linking Ser307 phosphorylation to insulin resistance in whole
animals has been formally correlative in nature. In one excep-
tional study, it was recently shown that transgenic mice express-
ing triply mutated (Ser302/307/612/Ala) Irs1 in their skeletal
muscle are protected against development of HFD-induced
insulin resistance (Morino et al., 2008); however, the incom-
pletely reductive design of this study makes it impossible to infer
the specific contribution of Ser307. In contrast, we observed
significant insulin resistance in high-fat-fed Ser307Ala knockin
mice (A/A), suggesting that the enhanced sensitivity of Ser302/
307/612 /Ala transgenic mice may owe to mutation of
Ser302, Ser612, or both sites together.
In established cells that overexpress the IR and Irs1, Ser307
was previously shown to be required for the modest inhibition
of Irs1 Tyr phosphorylation caused by TNFa treatment (Aguirre
et al., 2000). However, another cell-based study found no effect
of a phosphomimetic Ser307Asp mutation on insulin-stimulated
glucose disposal, suggesting that Ser307 phosphorylation does90 Cell Metabolism 11, 84–92, January 6, 2010 ª2010 Elsevier Inc.not contribute substantially to insulin resistance (Weigert et al.,
2008). Compatible with this result, we observed mild effects of
the Ser307Ala mutation in chow-fed A/A and A/+ mice that
nevertheless progressed to insulin resistance upon high-fat
feeding or deletion of hepatic Irs2. In further contrast with estab-
lished cell lines (Aguirre et al., 2000; Weigert et al., 2008), both
HFD-fed A/A mouse muscles and primary hepatocytes from A/
lox::LKO2 mice displayed slightly reduced or unchanged
tyrosyl phosphorylation of A307Irs1 following insulin stimulation.
In both cases, this was accompanied by decreased insulin-stim-
ulated binding of PI3K to Irs1, without a marked decrease in Akt
phosphorylation. In muscles of HFD-fed A/A mice, this may have
owed to Akt activation via the Irs2 pathway; however, it is also
possible that we did not choose the appropriate time to monitor
Akt phosphorylation, which is typically rapidly saturated and long
lasting. We conclude that Ser307 in whole animals promotes
insulin sensitivity through a moderate, but physiologically signif-
icant, effect to maintain PI3 kinase binding to Irs1.
As in other animal-based studies (e.g., Um et al., 2004), we
noted significant stimulation of Ser307 phosphorylation by
insulin, even in tissues of HFD-fed mice. Further, in primary
hepatocytes infected with WT Irs1 adenovirus, Ser307 was
strongly phosphorylated by insulin treatment. While these
data are compatible with a positive role of Ser307 in signaling
by Irs1, in other experiments we found that only a fraction of
the total Irs1 in muscles of chow-fed mice or WT hepatocytes
is phosphorylated on Ser307 by insulin stimulation (K.D.C.
and M.F.W., unpublished data). Thus, Ser307 phosphorylation
is not a sine qua non for signaling via Irs1 but may function
to maintain signaling by the Ser307-phosphorylated fraction.
Fluctuation in the size of this fraction—for example, as influ-
enced by diet—might therefore have modulated the severity
of physiologic and signaling defects observed in our studies.
The phosphorylation of other Ser/Thr sites is also likely to
have affected Irs1 function; however, we did not observe mark-
edly different phosphorylation of WT and A307 Irs1 at eight
other Ser/Thr sites in adenovirus-infected hepatocytes, sug-
gesting that the insulin resistance of A/A mice owed primarily
to the effect of Ser307 status. Thus, despite clear upregulation
of Ser307 phosphorylation in animal models of insulin resis-
tance, this modification may have an adaptive, rather than path-
ogenic, function. Extension of the knockin mouse approach
used here to other Ser/Thr sites will help to determine how
common, or rare, this function might be.
EXPERIMENTAL PROCEDURES
Mice and Diets
Mouse procedures were approved by the Children’s Hospital IACUC. The
conditional Irslox allele was previously described (Dong et al., 2008). Produc-
tion and genotyping of IrsA/A (A/A) and IrsS/S (S/S) knockin mice are detailed
in the Supplemental Information. The diets (PMI Nutrition Intl., Richmond, IN)
were chow (Prolab Isopro, #5P76; 14 kcal% of energy from fat of diverse sour-
ces) and HFD (Surwit 5800-B, #58R3; 58 kcal% in fat from hydrogenated
coconut oil). Mice in Figures 1–3 were progeny of inbred (C57BL/6; n = 9+)
Irs1A/+ or Irs1S/+ pairs. Breeding of the mice in Figure 4 is detailed in the
Supplemental Information.
Metabolic Assays
For GTT, mice were fasted for 16 hr, blood was drawn, and mice were injected
intraperitoneally (i.p.) with 2 g/kg glucose. For ITT, blood was drawn beginning
Cell Metabolism
Irs1 Ser307 Promotes Insulin Sensitivity in Mice3 hr after the end of dark phase, after which mice were fasted 4 hr, then in-
jected i.p. with insulin (Lilly, Humulin R). AUCs were calculated by summation
of trapezoids. Plasma insulin was measured by ELISA (Crystal Chem.) using rat
insulin standard.Isolation of Primary Cells
MEF cells were isolated as described (Bruning et al., 1997) using embryos from
Irs1A/S (A/S) mating pairs. Frozen primary MEFs (p0) were thawed and grown to
70% confluency, then reseeded in DMEM plus 10% FBS on plates corre-
sponding to treatments shown. Upon confluency, MEFs were washed twice
with serum-free DMEM and incubated a further 16 hr without serum before
insulin treatment. Isolation and culture of mouse hepatocytes is detailed in
the Supplemental Information.Tissue Collection and Analysis
Pancreatic b cell area was measured as described (Kushner et al., 2004) in
5- to 6-month-old male chow- and HFD-fed mice (n = 6 and 7–10 per group).
For immunoblots, mice were fasted 16 hr, then injected via the vena cava with
5 U of Humulin R (Lilly) under anesthesia; tissues were collected after 5 min and
frozen in liquid nitrogen. To assay S6K phosphorylation, fasted mice were
instead refed for 1 or 2 hr and sacrificed by CO2 asphyxiation; consumption
of chow was confirmed by monitoring blood glucose and stomach contents.
Tissues were lysed and analyzed as described (Dong et al., 2008) using anti-
bodies described in the Supplemental Information.Adenovirus Injection
Male LDKO mice (6- to 8-week-old) were injected via the tail vein with 2 3
1010 pfu of soft agar-titerd Ad-WT or Ad-A307. The ITT assay was performed
5 days after virus injection using 0.8 U/kg of insulin.Statistical Treatment and Graphs
Significance was assessed at the 95% level using the Kruskal-Wallis (K-W)
and Mann-Whitney (M-W) tests (SPSS, v16). For three or more groups, an
overall difference in data location of at least one of the groups was assayed
using the K-W (H) test; where found, this was followed by pairwise M-W (U)
tests (with Bonferroni correction of a) to identify differences between
groups. For two groups, the M-W test was used. Except in Figure 4, where
reduction of allelic number or the mutant allele was expected to worsen
insulin sensitivity, p values were calculated from the two-tailed X 2 distribu-
tion. Effect size (Pearson’s r) was calculated from the z score of the M-W
test. In Figures 3A–3D and Figures S2B and S2C, estimated means normal-
ized to the average concentration of the protein of interest (Irs1, Irs2, or
tubulin for Akt) were determined with a generalized linear model (SPSS
v16) assuming a normal distribution of the response, an identity link, and
the concentration of the protein of interest as a covariate. In each case,
the Bonferroni p values are reported to correct for multiple comparisons.
Except as indicated, bars and error bars in graphs represent the mean
and standard error of the mean.SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.cmet.2009.11.003.ACKNOWLEDGMENTS
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